Literature DB >> 11369028

Regulation of spontaneous inhibitory synaptic transmission by endogenous glutamate via non-NMDA receptors in cultured rat hippocampal neurons.

M Vignes1.   

Abstract

The regulation of gamma-aminobutyric acid (GABA)-mediated spontaneous inhibitory synaptic transmission by endogenously released glutamate was studied in cultured rat hippocampal neurons. After 7 days in vitro (DIV), both spontaneous excitatory postsynaptic currents (sEPSCs) and spontaneous inhibitory postsynaptic currents (sIPSCs) could be detected. After 15 DIV, most postsynaptic spontaneous currents occurred as sEPSC/sIPSC sequences when recorded at a holding voltage of -30 mV. In the presence of the glutamate alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor subtype antagonist LY303070, both the frequency and amplitude of sIPSC were strongly and reversibly reduced. The N-methyl-D-aspartate (NMDA) receptor antagonist, 2-amino-5-phosphonopentanoic acid (AP5), had no effect on sIPSC while cyclothiazide strongly increased sIPSC frequency. Under blockade of AMPA receptors, the kainate- and GluR5-selective kainate receptor agonists, (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid) (ATPA) and (S)-5-iodowillardiine (5IWill), induced a large enhancement of the frequency of small-amplitude sIPSC which was blocked by the non-NMDA receptor antagonist, 2,3-dihydro-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX). All of these effects were sensitive to tetrodotoxin (TTX). In the presence of LY303070 and TTX, kainate could induce a small inward current while GluR5 agonists had no effect. In the presence of NMDA and AMPA receptor antagonists, the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid (t-PDC) could restore sIPSC. When NBQX was used as an AMPA antagonist, the stimulatory effect of t-PDC was blocked while the group I metabotropic glutamate agonist, 3,5-dihydroxyphenylglycine (DHPG), induced a strong enhancement of sIPSC. Therefore, both AMPA and kainate receptors can regulate inhibitory synaptic transmission in cultured hippocampal neurons, the former by tonic activation, the latter when the glutamate concentration is increased by impairing glutonate uptake.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11369028     DOI: 10.1016/s0028-3908(00)00213-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  AMPA/kainate receptor-mediated downregulation of GABAergic synaptic transmission by calcineurin after seizures in the developing rat brain.

Authors:  Russell M Sanchez; Weimin Dai; Rachel E Levada; Jocelyn J Lippman; Frances E Jensen
Journal:  J Neurosci       Date:  2005-03-30       Impact factor: 6.167

2.  Cyclothiazide selectively inhibits mGluR1 receptors interacting with a common allosteric site for non-competitive antagonists.

Authors:  Alexander Surin; Sergey Pshenichkin; Ewa Grajkowska; Elena Surina; Jarda T Wroblewski
Journal:  Neuropharmacology       Date:  2006-11-07       Impact factor: 5.250

Review 3.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Endogenous activation of kainate receptors regulates glutamate release and network activity in the developing hippocampus.

Authors:  Sari E Lauri; Mikael Segerstråle; Aino Vesikansa; Francois Maingret; Christophe Mulle; Graham L Collingridge; John T R Isaac; Tomi Taira
Journal:  J Neurosci       Date:  2005-05-04       Impact factor: 6.167

Review 5.  Towards a Better Understanding of GABAergic Remodeling in Alzheimer's Disease.

Authors:  Karan Govindpani; Beatriz Calvo-Flores Guzmán; Chitra Vinnakota; Henry J Waldvogel; Richard L Faull; Andrea Kwakowsky
Journal:  Int J Mol Sci       Date:  2017-08-21       Impact factor: 5.923

6.  Current Study of the Mechanism of Action of the Potential Anti-Epileptic Agent Q808.

Authors:  Xiang Li; Hong-Jian Zhang; Qing Wang; Dian-Wen Zhang; Di Wu; Wei Li; Zhe-Shan Quan
Journal:  Molecules       Date:  2017-07-07       Impact factor: 4.411

7.  The Glutathione Metabolite γ-Glutamyl-Glutamate Partially Activates Glutamate NMDA Receptors in Central Neurons With Higher Efficacy for GluN2B-Containing Receptors.

Authors:  Fatiha Sebih; Nawfel Mokrane; Pierre Fontanel; Mete Kayatekin; Mahira Kaabeche; Janique Guiramand; Catherine Cohen-Solal; Thierry Cens; Matthieu Rousset; Pierre Charnet; Marie-Céleste De Jésus Ferreira; Jean-Baptiste Thibaud; Claudine Ménard; Sonia Cantel; Valérie Rolland; Michel Vignes; Julien Roussel
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.